Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

White House Releases Plan to Fight Antibiotic Resistance

By Drug Discovery Trends Editor | March 27, 2015

The White House has revealed today its comprehensive plan to tackle antibiotic resistance within the next five years, according to a copy of the 60-page report, which was reviewed by Reuters.

The goals include reducing the rates of the most deadly “superbug” infections, investing in new diagnostic tools and antibiotic drugs, improving antibiotic use, and surveillance of prescribing practices in hospitals, according to the report.

The threat posed by antibiotic-resistant bacteria is certainly serious. Repeated exposure to antibiotics has led bacteria to become resistant to drugs so that they can no longer treat a disease. The prevalence of antibiotic-resistant bacteria has affected drug development, as well, in which researchers must continuously anticipate a bacteria’s mutation—and the risk that a new antibiotic will no longer be effective.

According to the U.S. Centers for Disease Control and Prevention (CDC), antibiotic-resistant infections are linked to 23,000 deaths and 2 million illnesses in the U.S. annually.

Under the plan, the CDC will aim to reduce rates of the most deadly, widespread infections—including reducing Clostridium difficile infections by 50 percent, reducing carbapenem-resistant Enterobacteriaceae (CRE) infections by 60 percent and lowering Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections by at least 50 percent, reports Reuters.

Hospitals will also be required to implement programs to help reduce antibiotic use in patients. And doctors who work with government Medicare and Medicaid health plans will be required to report their prescribing patterns for antibiotics, especially when used to treat non-bacterial infections like common colds.

In an exclusive interview with Medscape, President Barack Obama talked about how his plan will address overprescribing. One way he hopes to do so is by providing real-time data about antibiotic resistance to doctors and hospitals nationwide to help them monitor local rates of drug resistance.

“Data is critical,” said President Obama. “We know that five out of six Americans are prescribed antibiotics each year. That adds up to 262 million antibiotic prescriptions annually…But we need to know more…If we can see where [antibiotics] are being prescribed, we can target our interventions where they’re needed most.”

In the Medscape interview, President Obama also said, “The federal government is making a long-term commitment to fighting drug resistance. That doesn’t just mean producing one batch of new antibiotics—it means creating a stronger drug pipeline, so American drug companies will keep producing new antibiotics well into the future. That’s key to staying ahead of drug resistance for the long run.”

Read the entire Medscape interview for more details.


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE